VetStem had the privilege of exhibiting at the 2025 Western Veterinary Conference (WVC) this week, one of the largest and most anticipated events in veterinary medicine. As leaders in regenerative medicine, VetStem showcased its innovative stem cell therapy and off-the-shelf PRP products, which are revolutionizing how veterinarians treat a number of diseases and injuries.

This year, we were excited to announce the news that we entered into an Exclusive License and Supply Agreement with Petvivo Animal Health, Inc. to commercialize our innovative allogeneic orthobiologic products, PrecisePRP™ Canine and PrecisePRP™ Equine. PrecisePRP™ is a groundbreaking, off-the-shelf platelet-rich plasma (PRP) product designed for ease of use by veterinarians. Unlike traditional PRP mechanical kits that require a blood draw and centrifugation, PrecisePRP™ is ready-to-use, offering veterinarians a truly off-the-shelf product that is easy and convenient. More importantly, PrecisePRP™ ensures uniformity and consistency with its unique patent-pending manufacturing process and quality testing.

Additionally, attendees had the opportunity to learn about VetStem’s groundbreaking advancements in stem cell technology, which are helping thousands of pets recover from injuries, arthritis, and other challenging conditions like renal disease, inflammatory bowel disease, gingivostomatitis, back pain/IVDD, and dry eye.

We were thrilled to connect with veterinarians and industry professionals at the event. It was a great opportunity to share how VetStem’s regenerative solutions are improving the health and quality of life for animals everywhere. Thank you to everyone who stopped by and made our time at WVC 2025 such a success. We look forward to continuing to drive advancements in veterinary care and supporting the veterinary community in the years to come!